Dose response relationships for Listeria monocytogenes in ready-to-eat foods

Similar documents
From Experimental Infections in Animals to Quantifying Subtypes in Foods: Data Collection for L. monocytogenes Dose-Response

FDA-iRISK A Comparative Risk Assessment System for Evaluating and Ranking Food-Hazard Pairs: Case Studies on Microbial Hazards

Limitations of Risk Assessment Based on Non Fit-For Purpose/Invalidated Laboratory Methods

Chapter X. Campylobacter jejuni and Campylobacter coli

Dose response for Listeria monocytogenes

Chapter 3 Campylobacter jejuni and Campylobacter coli

Part 4. Example Risk Assessments

Risk analysis of foodborne antimicrobial resistance (AMR) Suphachai Nuanualsuwan DVM, MPVM, PhD1

Quantitative risk assessment of Listeria monocytogenes in milk and milk products. O. Cerf & M. Sanaa Alfort Veterinary School

Supplemental Information Dose Response Parameters for Gain of Function Pathogens

MRA basic awareness course

Chemical & Microbial Risk Assessment: Case studies to demonstrate similarities and differences

Genetic markers linked to and/or responsible for Listeria monocytogenes virulence attenuation Martin Wiedmann Department of Food Science Cornell

Listeria monocytogenes Risk Assessment: Executive Summary

Risk Assessment Report Listeria monocytogenes in foods

Report of the Joint FAO/WHO Expert Consultation on Risk Assessment of Microbiological Hazards in Foods. FAO Headquarters, Rome, Italy

Quantitative microbial risk assessment exemplified by Staphylococcus aureus in unripened cheese made from raw milk

QMRA in the Built Environment

Managing Risk in a Zero Tolerance World: International Impact of Risk Assessment

Outsourcing activity 2: quantitative risk characterization on L. monocytogenes in RTE foods

Possible Modes of Transmission of Avian Viruses to People: Studies in Experimental Models

The roadmap. Why do we need mathematical models in infectious diseases. Impact of vaccination: direct and indirect effects

Chapter 4 Coxiella burnetii

MICROBIOLOGY - An Overview

Simplified Modeling Framework for Microbial Food-Safety Risk Assessments

Those Pathogens, What You Should Know

Bacillus anthracis. Summary Data

Effect of Host Species on the Dose Response of Inhaled Bacillus anthracis Spores

Inference Methods for First Few Hundred Studies

Food Safety. Professor Christine Dodd Division of Food Sciences

Dynamics and Control of Infectious Diseases

Quantitative risk assessment of Listeria monocytogenes in ready-to-eat foods: the FAO/WHO approach

Cancer projections National Cancer Registry

FDA-iRISK A Comparative Risk Assessment System for Evaluating and Ranking Food-Hazard Pairs: Case Studies on Microbial Hazards

Old bugs in new places The changing face of food safety microbiology

Listeria whole-genome-sequencing EFSA Project. Anses Statens Serum Institut Public Health England University of Aberdeen

3-MCPD and glycidol and their esters

DISCUSSION GROUP 3. Mechanism of carcinogenicity. EFSA Scientific Colloquium on Acrylamide carcinogenicity, 22/23 May

Vaccine Efficacy, Effectiveness and Impact. G. HANQUET, KCE, 9 September 2017

6.3.5 Uncertainty Assessment

Food Safety Performance Standards: an Epidemiologic Perspective

California Food Emergency Response Team (CalFERT)

CHAPTER TWO MECHANISMS OF RADIATION EFFECTS

Sample-size re-estimation in Multiple Sclerosis trials

Assessing Risks of Exposure to Allergens from Foods

A quantitative microbial risk assessment of helminth ova in reusing sludge for agricultural production in developing countries

TIME TO REACH PEAK HEAT RELEASE RATE: Nuclear Plant Electrical Enclosure Fires

Food Consumption Data in Microbiological Risk Assessment

CANCER AND LOW DOSE RESPONSES IN VIVO: IMPLICATIONS FOR RADIATION PROTECTION

Dose response modelling of staphylococcal enterotoxins using outbreak data: which model, which precision?

Campylobacter jejuni

Current status of Benchmark Dose Modeling for 3-Monochloropropane-1,2-diol (3-MCPD)

33. I will recommend this primer to my colleagues. A. Strongly Agree D. Disagree B. Agree E. Strongly Disagree C. Neither agree nor disagree

Opportunities to Collect Data and Improve Lm Risk Assessments

Microbiological Quantitative Risk Assessment and Food Safety: An Update

APPLICATION FOR AUTHORISATION: ESTABLISHING A REFERENCE DOSE RESPONSE RELATIONSHIP FOR CARCINOGENICITY OF INORGANIC ARSENIC COMPOUNDS

E. coli O157:H7 - Multistate Outbreak Associated with Hazelnuts, 2010

Joint EFSA-ECDC ROA on multi-country outbreak of Listeria monocytogenes. Valentina Rizzi, scientific officer, BIOCONTAM Unit

Food Safety and Inspection Service: Food Safety and Inspection Service Click to edit Master title style

Dose response relationships: biological and modeling aspects

CHAPTER 4: DISEASES SPREAD BY FOOD AND WATER

INTRODUCING YOUR GUT BACTERIA

To what extent is the consumer exposed to L. monocytogenes by consuming RTE foods? Kostas Koutsoumanis

Development of NJ Human Health-based Criteria and Standards

Use of Microbial Risk Assessment in Decision-Making

MICROBIAL SAFETY OF READY-TO-USE LIPID-BASED THERAPEUTIC AND SUPPLEMENTARY FOODS. Conclusions and Recommendations of an FAO/WHO Technical Meeting

MODELLING THE SPREAD OF PNEUMONIA IN THE PHILIPPINES USING SUSCEPTIBLE-INFECTED-RECOVERED (SIR) MODEL WITH DEMOGRAPHIC CHANGES

Listeria monocytogenes contamination of ready-to-eat foods and the risk for human health in the EU

1, 2, 3-Trichloropropane (TCP): Assessment of Risks from Drinking Water

Statistical Tolerance Regions: Theory, Applications and Computation

Impact of Sodium Reduction on Survival of Listeria monocytogenes in Sliced Process Cheese

Retrospective Outbreak Investigations Initiated by Product or Environmental Sampling. LCDR Kari Irvin November 19, InFORM

Bayesian Prediction Tree Models

RISKS ASSESSMENT IN ROMANIAN FOOD SAFETY SYSTEMS: OPPORTUNITIES AND CONSTRAINS. Abstract

Report to the Technical Consultative Committee (TCC) Recommended Product Safety Limits for the NZ Dairy Industry

Lm Regulatory Update

Modeling and simulation of infectious diseases for quantitative microbial risk assessment (QMRA)

Practical considerations on food safety objectives

Chapter 23 Lassa virus. Lassa virus is a RNA virus belonging to the family of Arenaviridae. As the causative agent of

Quantitative Risk Assessment of Bacillus cereus in Pasteurised Milk Produced in the Slovak Republic

A first molecular characterization of Listeria monocytogenes isolates circulating in humans from 2009 to 2014 in the Italian Veneto region

Statistical Science Issues in HIV Vaccine Trials: Part I

Document downloaded from:

Transmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos

The Costs of Human Salmonellosis Attributable to Pork: A Stochastic Farm-to-Fork Analysis

Kraemer Science Olympiad Invitational Disease Detectives Test January 2017

Malik Sallam. Ola AL-juneidi. Ammar Ramadan. 0 P a g e

International Regulation for Listeria monocytogenes Control in RTE Foods

On shelf life of foods

Asian Journal of Food and Agro-Industry ISSN Available online at

Control of Listeria monocytogenes in Ready-to-Eat Foods: Draft Guidance

Possible Consequences of Inhomogeneous Suborgan Distribution of Dose and the Linear No-Threshold Dose-Effect Relationship

Overview of a Risk Assessment Model for Enterobacter sakazakii in Powdered Infant Formula

What are the challenges in addressing adjustments for data uncertainty?

Global Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today

The power of information to prevent foodborne illness

Modelling of inactivation through heating for quantitative microbiological risk assessment (QMRA)

Listeria monocytogenes. Tom Duszynski, MPH, REHS Director of Surveillance and Inves>ga>on

Part I. Boolean modelling exercises

U.S. Low Dose Radiation Research Program

Transcription:

Dose response relationships for Listeria monocytogenes in ready-to-eat foods Roland Lindqvist 5th ASEPT International Conference of risk analysis and Listeria monocytogenes March 17-18, 2004 LAVAL - France

Factors affecting Dose-response Infectious Disease Triangle

Factors affecting Dose-response Food Protection against physiological barriers Induction of stress response Effects on transport through GI tract Host Age Immune status / underlying conditions Medications Pregnancy Pathogen Survival properties of pathogen Virulence /pathogenic mechanisms Strain variability Antibiotic resistance

End-point of Dose-response model Major steps in infectious disease process End-points in available DR-models for L. monocytogenes infection, illness (morbidity), death (mortality) no conditional models (infection given exposure, illness given infection, etc.)

Sources of data Human volunteer feeding studies best direct measure of response healthy individuals, high doses, low dose extrapolation not available for L. monocytogenes Surrogate animals many of the limitations as human data need conversion factor same mechanisms? (ex. mouse and guinea pig)

Sources of data Epidemiological data may be used to evaluate dose-response models outbreak data - information often missing surveillance/health statistics - depends on the system cost effective, include whole population and range of strains Expert elicitation if lack of data, e.g. input on parameter values subjective, dependent on methodology

Dose-response: concepts Probability of response 1.00 0.90 0.80 0.70 0.60 0.50 0.40 0.30 0.20 0.10 0.00 WHO/FAO guidelines 0 1 2 3 4 5 6 7 8 9 Dose (log cfu) non-threshold threshold single-hit, non-threshold models linear in the low-dose region biological basis, biologically interpretable parameters density dependence? (e.g. quorum sensing)

Dose-response: models Exponential non-threshold model, linear in low-dose region host/pathogen interaction constant, described by r r is the probability of a single bacterium to cause illness (infection, mortality) P = 1 - e -r*dose Beta-Poisson non-threshold model, linear low-dose host/pathogen interaction variable; r follows a beta distribution, described by α and β If β >> than α and 1 then P = 1 - [1 + dose/ β] - α

Dose-response: models Weibull-Gamma single hit, linear low-dose host/pathogen interaction variable, follows a beta distribution, described by α and β Includes a third parameter, b, determining shape P = 1 - [1 + (dose) b / β] - α

Models based on epidemiological data and expert elicitation Farber et al 1996, Bemrah et al, 1998 Dose-infection model Weibull-Gamma model general and high risk populations, respectively ID 10 and ID 90 estimated based on literature data Buchanan et al.1997, Lindqvist & Westöö 2000 Dose-illness Exponential model Conservative assumptions, susceptible population Estimation of r by pairing exposure and illness data

Models based surrogate animals Notermans et al., 1998 dose-infection, dose-mortality exponential model based on data for mice and oral or intravenous exposure Haas et al, 1999 dose-infection beta-poisson better fit than exponential model based on data for mice and oral exposure

Models...combination surrogate animal and epidemiological data FDA/FSIS 2001 dose-mortality (X 5 gives dose-illness model) weighted combination of models based on goodness of fit based on mice data and oral exposure, but anchored to human epidemiological data models includes variability in virulence general population, elderly, and perinates/neonates

Models prior to WHO/FAO risk assessment Probability of response 1.00 0.90 0.80 0.70 0.60 0.50 0.40 0.30 0.20 0.10 0.00 Buchanan Haas Farber criteria for selection WHO/FAO guidelines purpose resources available 0 1 2 3 4 5 6 7 8 9 10 1112 Dose (log cfu)

WHO/FAO dose-response model Approach Buchanan et al.: Pairing exposure and statistics on number of illnesses using the exponential model exposure data and epi-data from US Listeria risk assessment uncertainty in input data addressed: # of cases, susceptible population, # cases in population, maximum dose in serving Assumptions exponential model appropriate for dose-response relation r is a constant model reflects mean on population basis strain and host variability reflected in the mean characteristics same consumption in susceptible and non-susceptible

No of cases = [1-(e -r*dose )] * No of servings

WHO/FAO dose-response model Uncertainty the estimation of r is highly dependent on the accuracy of input data; uncertainty in the data and changes in terms of the distribution of pathogen virulence or host susceptibilities Assumption of maximum dose in a serving had the largest effect on the estimation of r, compared to the no. of cases, the fraction of susceptible consumer, and the no. of cases in the population of interest

WHO/FAO dose response model Uncertainty in exposure Illustration of the effect of uncertainty in exposure: Chen et al. (2003) used same approach, exponential model but new data to estimate exposure and illness. r estimated to 1.8x10-10 Including potential for growth (purchase-consumption) r estimated to 8x10-12

Presumed Maximum log 10 DoseLogDose7.58.59.510.5- Assuming all cases due to highest dose only or to all dose levels had minor effect

Illustration of model uncertainty use beta-poisson model (Haas) based on infection in mice anchor to the number of cases assuming Probability of illness is constant at any dose given infection maximum dose in serving 9.5 log cfu Probability of response 1 0.01 0.0001 1E-06 1E-08 1E-10 1E-12 0 2 4 6 8 10 12 14 Haas Pill Beta-Poisson WHO/FAO Difference in slope % cases due to serving with dose >4.5 log cfu WHO/FAO: > 99.3 % BP: 75 % dose (log cfu)

Comparison with other models Probability of illness 1E+00 1E-02 1E-04 1E-06 1E-08 1E-10 1E-12 1E-14 0 2 4 6 8 10 12 14 WHO/FAO FDA elderly WHO/FAO FDA neonates FDA elderly FDA neonates butter outbreak cheese outbreak (FDA models approximated to exponential) Dose (log cfu)

Probability of illness 1.00 0.90 0.80 0.70 0.60 0.50 0.40 0.30 0.20 0.10 0.00 0 2 4 6 8 10 12 14 WHO/FAO FDA elderly FDA neonates butter outbreak cheese outbreak Dose (log cfu) Small r-values corresponds to unrealistic large ID 50 a substantial variation in the susceptible population and/or in the virulence of strains

Summary of knowledge gaps Absence of human feeding trial data Incomplete epidemiological information Uncertain extrapolations animals to humans Lack of mechanistic models Understanding of strain variation Understanding of food matrix effects